Mitochondrial mutations in subjects with psychiatric disorders

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Mitochondrial dysfunction is implicated in psychiatric disorders.
• Mitochondrial DNA (mtDNA) mutations affect brain energy, neurotransmission, and can cause neurodegeneration.
• Previous studies focused on nuclear genome variants, neglecting mtDNA variations.

Purpose of the Study:

• To investigate the role of mtDNA variation in bipolar disorder, schizophrenia, major depressive disorder, and methamphetamine use.
• To utilize next-generation sequencing for comprehensive mtDNA analysis.
• To compare mtDNA variants in psychiatric cases with a large reference database.

Main Methods:

• Sequencing of mtDNA from multiple brain regions and blood (121 samples, ~8,800x coverage).
• Comparison against a database of 26,850 mtDNA genomes.
• Validation of variants and sequencing hotspots using traditional methods.

Main Results:

• Significant increase in non-synonymous mtDNA mutations observed in schizophrenia patients.
• Novel and rare non-synonymous mutations identified in specific mtDNA genes (ND6, ATP6, CYTB, ND2) in psychiatric cases.
• Mitochondrial heteroplasmy and multiplasmy detected in brain tissue, with variable levels across regions and higher frequency in cases.

Conclusions:

• Findings support increased rates of mtDNA substitutions in schizophrenia.
• Variable heteroplasmic/multiplasmic somatic mutations in the brain may indicate mtDNA genetic instability.
• mtDNA variations represent a potential factor in the pathophysiology of psychiatric disorders.